John Mendelsohn, president, MD Anderson Cancer Center
Harry Miao, director of CEP oncology, Sanofi-Aventis
Christine Mikail, senior vice president of corporate development, Savient Pharmaceuticals
Michael Misocky, president and CEO, Misocky Consulting Group
Mike Mitchell, senior account manager, oncology payer services, Lilly Oncology
Lissette Nale, site operations planner, Merck
Dennis Nazareno, associate director, clinical systems business process, Celgene
Mike Needle, associate professor of clinical pediatrics, Columbia University Medical Center
Daniel O’Connor, vice president & general counsel, Bracco Diagnostics [Updated: 10:20 pm, 4/15/11]
William Parson, associate vice president, environmental health and safety, ImClone Systems, a subsidiary of Eli Lilly
Bankim Patel, vice president of facilities, engineering and validation, ImClone Systems, a subsidiary of Eli Lilly
Kevin Peacock, director of new product planning, Allos Therapeutics
Mark Perdue, senior account manager, oncology payer services, Lilly USA
Dan Pereira, senior director, discovery research, Agensys, a subsidiary of Astellas Pharma
Charles Perez, associate director IT production services, ImClone Systems, a subsidiary of Eli Lilly
Thomas Perone, corporate counsel, Celgene
David Pirrotta, scientist II, Pfizer
Kevin Plant, systems administrator, ImClone Systems, a subsidiary of Eli Lilly
Eric Poma, president and CEO, Molecular Templates
Ron Pomerantz, national account manager, Seattle Genetics
Nancy Prata, human resources manager, Celgene
Philippe Pultar, senior medical director, clinical development, ImClone Systems, a subsidiary of Eli Lilly
Andrea Rabney, co-founder and senior partner, Argot Partners
Venkat Ramakrishnan, regional business manager, mid-Atlantic, OSI Oncology
Erik Ramanathan, executive director, program on the legal profession, Harvard Law School
Viren Rana, manufacturing scientist, Progenics Pharmaceuticals
Anne Marie Robertson, U.S. group leader, Pfizer
Richard Ross, area sales director, Genomic Health
Eric Rowinsky, co-founder and CEO, Primrose Therapeutics
Karen Rutkowski, AVP of medical information, ImClone Systems, a subsidiary of Eli Lilly
